U.S. Department of Health and Human Services
NATIONAL INSTITUTES OF HEALTH NIH News
National Institute of Allergy and Infectious Diseases (NIAID) <https://www.niaid.nih.gov>
For Immediate Release: Tuesday, August 28, 2018
CONTACT: Judith Lavelle, 301-402-1663, <e-mail:NIAIDNews@xxxxxxxxxxxxx>
MEDIA AVAILABILITY
HIV/AIDS RESEARCH YIELDS DIVIDENDS ACROSS MEDICAL FIELDS
Nearly four decades of study has propelled advances in heart disease, hepatitis, cancer and other diseases
WHAT:
Since the first cases of AIDS were reported in the United States 37 years ago, the National Institutes of Health has invested more than $69 billion in the understanding, treatment and prevention of HIV/AIDS. Beyond the development of life-saving medications and innovative prevention modalities, such research has led to numerous advances outside the HIV field, according to a new commentary from experts at NIH's National Institute of Allergy and Infectious Diseases (NIAID).
Writing in the Journal of Infectious Diseases, NIAID Director Anthony S. Fauci, M.D., and his colleague Tara A. Schwetz, Ph.D., note that researchers have gleaned critical insights from the devastation HIV can unleash on the immune system. Scientists now better understand the vital role of CD4+ T cells <https://www.flickr.com/photos/niaid/30107399504/> -- immune cells that HIV selectively infects and destroys -- in thwarting other infectious diseases and certain cancers. Studying the course of HIV infection has furthered understanding of persistent immune activation and inflammation that can appear in other diseases. For example, researchers observed that inflammation led to a heightened risk of heart disease in people living with HIV, prompting further inquiry into the role of inflammation in heart disease regardless of a person's HIV status. HIV research also has provided insight into other HIV-associated comorbidities, including kidney disease, cancer and tuberculosis.
Research focused on HIV treatments and vaccines also has reaped wide-ranging benefits. Efforts to develop antiretroviral therapy for HIV provided a model for targeted drug development that has been applied to the discovery of other antiviral drugs, such as direct-acting antivirals that can cure hepatitis C virus infection. Techniques developed for the discovery of broadly neutralizing antibodies and candidate vaccines inducing these antibodies against HIV are being explored to combat other viral diseases such as Ebola, Zika and influenza. In addition, studies focused on the molecular structure of HIV have ushered in an era of structure-based vaccine design.
These and other examples, the experts conclude, indicate that HIV/AIDS research has had and continues to have a far-reaching impact well beyond this single pathogen.
ARTICLE:
TA Schwetz and AS Fauci. The Extended Impact of HIV/AIDS Research. Journal of Infectious Diseases DOI: 10.1093/infdis/jiy441 (2018).
WHO:
Anthony S. Fauci, M.D., NIAID director and co-author of the editorial, is available for comment.
CONTACT:
To schedule interviews, please contact Judith Lavelle, (301) 402-1663, niaidnews@xxxxxxxxxxxxx.
NIAID conducts and supports research -- at NIH, throughout the United States, and worldwide -- to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website <https://www.niaid.nih.gov/>.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <www.nih.gov>.
NIH...Turning Discovery into Health -- Registered, U.S. Patent and Trademark Office
###
This NIH News Release is available online at:
<https://www.nih.gov/news-events/news-releases/hiv-aids-research-yields-dividends-across-medical-fields>
To subscribe (or unsubscribe) from NIH News Release mailings, go to
<http://service.govdelivery.com/service/subscribe.html?code=USNIH_1>.
If you subscribed via the NIH LISTSERV, go to <https://list.nih.gov/cgi-bin/wa.exe?A0=nihpress>.
